AVITA Therapeutics, Inc. Announces Executive Change
November 05, 2020 22:30 ET
|
AVITA Medical
VALENCIA, Calif. and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company that is developing and commercializing...
Avita Therapeutics, Inc. Announces Correction of Time for the Adjourned 2020 Annual Stockholder Meeting
November 05, 2020 07:46 ET
|
AVITA Medical
VALENCIA, Calif, and MELBOURNE, Australia, Nov. 05, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing...
AVITA Therapeutics Announces Date Change for First Quarter 2021 Earnings Release and Conference Call
November 03, 2020 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
AVITA Therapeutics, Inc. Announces Adjournment of 2020 Annual Stockholder Meeting
October 29, 2020 19:29 ET
|
AVITA Medical
VALENCIA, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
AVITA Therapeutics to Participate in Upcoming Investor Conferences
October 28, 2020 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Oct. 28, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...
AVITA Therapeutics to Announce First Quarter 2021 Financial Results
October 27, 2020 16:01 ET
|
AVITA Medical
VALENCIA, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) -- AVITA Therapeutics, Inc. (NASDAQ: RCEL, ASX:AVH), a regenerative medicine company that is developing and commercializing a technology platform...